• to reduce the potential risk of serious cardiovascular (heart and blood vessel) difficulties in Grownups with type two diabetes and cardiovascular diseaseAllergic reaction: You shouldn't choose Rybelsus or copyright When you are allergic to either drug, its ingredients, or A further GLP-1 agonist drug.By 2022 the recognition of Novo's Wegovy an